SABBY MANAGEMENT, LLC - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is NTEC and the CUSIP is M53644148. A total of 12 filers reported holding INTEC PHARMA LTD JERUSALEM in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q1 2021$164,000
+368.6%
37,501
+267.7%
0.03%
+357.1%
Q4 2020$35,00010,1990.01%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q2 2021
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 443,008$1,537,0000.21%
GSA CAPITAL PARTNERS LLP 33,291$116,0000.01%
MEITAV INVESTMENT HOUSE LTD 241,982$840,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 50$00.00%
MORGAN STANLEY 34,818$121,0000.00%
Citadel Advisors 12,357$43,0000.00%
Steward Partners Investment Advisory, LLC 110$00.00%
Cutler Group LLC / CA 125$00.00%
Squarepoint Ops LLC 19,200$67,0000.00%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders